News

Over seven in ten are uncertain about legal liability in AI usage.

However, insurers are pursuing profitability and program stability over the long term.

Annual Premium Equivalent by 14.4%.

Over 1 in 3 Asian companies are looking to trade more with South Asia and Europe whilst over 1 in 4 plan to trade less with North America, according to a 2025 survey by HSBC.

The estimated drug-treated population may grow to over 25,100,000 people.

There is increased corporate demand for liquidity and risk coverage, says HSBC.

Thanks to declining costs and policy support.

The rare neurogenetic disorder affects around 500,000 people worldwide.

Digitalisation is shifting the sector to an integrated service ecosystem.

China led Asia’s life insurance recovery.

The global advancement of its legislation is a key growth driver.

Reforms are needed to address the possible energy transition gap.

Antibody-drug conjugates dominated licensing activity in 2024.

Over half of CEOs now rank it among their top three priorities, according to McKinsey.

Rising medical trend rates are significantly outpacing salary increases.

Cybersecurity remains the leading risk in the region, cited by 62% of APAC CROs.